158 related articles for article (PubMed ID: 19760177)
1. FHIT gene sequence variants and reduced Fhit protein expression in glioblastoma multiforme.
Cecener G; Tunca B; Egeli U; Bekar A; Guler G; Tolunay S; Aksoy K
Cell Mol Neurobiol; 2010 Mar; 30(2):301-7. PubMed ID: 19760177
[TBL] [Abstract][Full Text] [Related]
2. Importance of novel sequence alterations in the FHIT gene on formation of breast cancer.
Ceçener G; Egeli U; Tunca B; Taşdelen I; Tolunay S; Bilgel N
Tumori; 2007; 93(6):597-603. PubMed ID: 18338496
[TBL] [Abstract][Full Text] [Related]
3. Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer.
Bekar A; Ceçener G; Tunca B; Guler G; Egeli U; Tolunay S
Tumori; 2007; 93(6):604-7. PubMed ID: 18338497
[TBL] [Abstract][Full Text] [Related]
4. Mutation analysis of the FHIT gene in bronchoscopic specimens from patients with suspected lung cancer.
Cecener G; Tunca B; Egeli U; Karadag M; Vatan O; Uzaslan E; Tolunay S
Tumori; 2008; 94(6):845-8. PubMed ID: 19267103
[TBL] [Abstract][Full Text] [Related]
5. Alterations of FHIT gene and P16 gene in nickel transformed human bronchial epithelial cells.
Ji WD; Chen JK; Lu JC; Wu ZL; Yi F; Feng SM
Biomed Environ Sci; 2006 Aug; 19(4):277-84. PubMed ID: 17044645
[TBL] [Abstract][Full Text] [Related]
6. [Mutations of fragile histidine triad gene in Peutz-Jeghers syndrome and canceration].
Zhao XR; Kang LC; Zhou YS; Jia YX; Chen Z; Kang SH; Li WM; Zhao M; Cui JT; Sun AL; Lu YY
Ai Zheng; 2003 Jan; 22(1):50-4. PubMed ID: 12561436
[TBL] [Abstract][Full Text] [Related]
7. Homozygous deletion of the FHIT gene, p21WAF1 protein expression and apoptosis in bilharzial bladder cancer.
Ghaleb KI; Alkaladi A
Pak J Biol Sci; 2011 Feb; 14(3):212-8. PubMed ID: 21870644
[TBL] [Abstract][Full Text] [Related]
8. Chromosome 3p14 alterations in lung cancer: evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos.
Nelson HH; Wiencke JK; Gunn L; Wain JC; Christiani DC; Kelsey KT
Cancer Res; 1998 May; 58(9):1804-7. PubMed ID: 9581816
[TBL] [Abstract][Full Text] [Related]
9. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
[TBL] [Abstract][Full Text] [Related]
10. FHIT alterations in lung adenocarcinomas induced by N-nitrosobis(2-hydroxypropyl)amine in rats.
Tsujiuchi T; Sasaki Y; Murata N; Tsutsumi M; Konishi Y; Nakae D
Carcinogenesis; 2001 Dec; 22(12):2017-22. PubMed ID: 11751434
[TBL] [Abstract][Full Text] [Related]
11. Abnormal transcripts of FHIT gene in Chinese brain tumors.
Tsai TC; Yang HM; Wu YL; Chi CW; Chou MD; Lee LS; Chang TJ
Oncol Rep; 1999; 6(2):345-8. PubMed ID: 10023002
[TBL] [Abstract][Full Text] [Related]
12. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
[TBL] [Abstract][Full Text] [Related]
13. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
[TBL] [Abstract][Full Text] [Related]
14. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic alterations of FHIT and p53 genes in benign and malignant thyroid gland lesions.
Pavelić K; Dedivitis RA; Kapitanović S; Cacev T; Guirado CR; Danić D; Radosević S; Brkić K; Pegan B; Krizanac S; Kusić Z; Spaventi S; Bura M
Mutat Res; 2006 Jul; 599(1-2):45-57. PubMed ID: 16698048
[TBL] [Abstract][Full Text] [Related]
16. Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer.
Sarli L; Bottarelli L; Azzoni C; Campanini N; Di Cola G; Bader G; Iusco D; Salvemini C; Caruso G; Donadei E; Pizzi S; D'Adda T; Renato C; Roncoroni L; Bordi C
Eur J Cancer; 2004 Jul; 40(10):1581-8. PubMed ID: 15196543
[TBL] [Abstract][Full Text] [Related]
17. Multiple molecular alterations of FHIT in betel-associated oral carcinoma.
Chang KW; Kao SY; Tzeng RJ; Liu CJ; Cheng AJ; Yang SC; Wong YK; Lin SC
J Pathol; 2002 Mar; 196(3):300-6. PubMed ID: 11857493
[TBL] [Abstract][Full Text] [Related]
18. FHIT mutations in human primary gastric cancer.
Gemma A; Hagiwara K; Ke Y; Burke LM; Khan MA; Nagashima M; Bennett WP; Harris CC
Cancer Res; 1997 Apr; 57(8):1435-7. PubMed ID: 9108441
[TBL] [Abstract][Full Text] [Related]
19. [Methylation status of FHIT gene in plasma and expression of FHIT gene in cancer tissue of cervical cancer patients].
Ren CC; Miao XH; Yang B; Zhao L; Sun R; Song WQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):565-7. PubMed ID: 17029211
[TBL] [Abstract][Full Text] [Related]
20. Homozygous deletion but not mutation of exons 5 and 8 of the fragile histidine triad (FHIT) gene is associated with features of differentiated thyroid carcinoma.
Yin DT; Wang L; Sun J; Yin F; Yan Q; Shen RL; Gao JX; He G
Ann Clin Lab Sci; 2010; 40(3):267-72. PubMed ID: 20689140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
